profit from every $100 of sales.
$0$100
WORK Medical Technology Group
$1.20-4.00% today
-99.9% in 1 year
1-year low $0.921-year high $3,535.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What WORK Medical Technology Group sold, what it kept, and what it did with the cash.
Sales went from $19.7 million in 2022 to $9.85 million in 2025, with -$1.07 million of profit last year.
SalesProfit
WORK Medical Technology Group vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| WORK Medical Technology Group | No profit yet | ||
 Abbott Laboratories | 28.8× · Fair price | ||
 Medtronic | 27.4× · Fair price | ||
 Stryker | 36.3× · Expensive | ||
 Edwards Lifesciences | 57.4× · Expensive |
AI analysis
An AI analyst reads WORK Medical Technology Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 20 | 14 | 12 | 10 | |
| 4 | 4 | 3 | 2 | |
| 2 | 0 | -4 | -1 | |
| 5 | 2 | -2 | 0 | |
| 1 | 0 | -3 | -1 | |
| 558.20 | 77.26 | -2,700.00 | – | |
| 22.4% | 30.5% | 24.9% | 23.8% | |
| 9.3% | 3.6% | -32.1% | -9.1% | |
| 4.4% | 0.8% | -30.4% | -10.9% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 26 | 30 | 36 | 33 |
| Cash | 1 | 2 | 7 | 4 |
| Total debt | 6 | 9 | 13 | 6 |
| Total liabilities | 14 | 19 | 20 | 12 |
| 10 | 10 | 13 | 18 | |
| 0 | 0 | 0 | – | |
| 7.1% | 2.1% | -9.2% | -1.8% | |
| 8.7% | 1.1% | -26.5% | -5.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2 | 2 | -2 | 6 | |
| 2 | 1 | 9 | 1 | |
| -4 | 2 | -11 | 5 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- –
- –
- –
- 0.0×
- 0.5×
- 1.1×
- 22.3×
- 91.6%
- -20.0%
- 0.0%
Profitability
- 23.8%
- -9.1%
- -10.9%
- -14.1%
- -1.9%
- -0.5%
- -6.9%
- -3.2%
- -11.8%
- 4.4%
Growth
- −20.6%
- –
- +142.8%
- –
- −3.7%
Financial health
- 6.8×
- 0.35
- 19.4%
- -1.1×
- 1.71
- 1.40
- 0.30
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 34%of 946
Bottom 15%of 871
Bottom 5%of 867
Top 1%of 986
News
Elon Musk joins 100,000+ signers on a petition to reinstate Jensen Huang — including 5,000+ who say they work at NvidiaYahoo Finance · Nov 14, 2026Microsoft Stock Falls as Anthropic Takes Aim at Office Work With New Claude ToolsYahoo Finance · Nov 11, 2026Depressing, but true: If you want to get ahead at work, embrace virtue signalingMarketWatch · Nov 4, 2026Grand Theft Callout: ‘GTA 6’ fans are missing work on the game’s release day because they ‘don’t want to wait’ anymoreMarketWatch · Nov 2, 2026International Paper projects Q4 Packaging Solutions North America adjusted EBITDA of $700M-$740M as EMEA separation work advancesSeeking Alpha · Oct 28, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
30No pass
Benjamin Graham
61Pass
Philip Fisher
27No pass
Peter Lynch
25No pass
Joel Greenblatt
0No pass
Charlie Munger
22No pass
Terry Smith
12No pass
Questions about WORK Medical Technology Group
Is WORK Medical Technology Group a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the WORK Medical Technology Group AI analysis
What does WORK Medical Technology Group do?
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. It is in Medical Devices.
Does WORK Medical Technology Group pay a dividend?
No. WORK Medical Technology Group does not pay a dividend at the moment.
Is WORK Medical Technology Group stock halal?
No. WORK Medical Technology Group does not pass our halal screen: its debt is 120% of its market value, at or above the 33% limit. How we check
How has WORK Medical Technology Group stock done over the past year?
Down 99.9% over the past twelve months, to $1.20. It traded between $0.92 and $3,535.00 and is 100.0% below its high.
Who are WORK Medical Technology Group's competitors?
The largest listed companies in the same industry are Abbott Laboratories, Medtronic, Stryker and Edwards Lifesciences. The peers table on this page compares their profit, growth and price with WORK Medical Technology Group's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.